Your browser doesn't support javascript.
loading
Biofilm prevention concentration of clarithromycin against clinically relevant species of nontuberculous mycobacteria.
Senhaji-Kacha, A; Akir, A; Broncano-Lavado, A; Esteban, J.
Affiliation
  • Esteban J; Jaime Esteban, MD, PhD.Department of ClinicalMicrobiology. IIS-Fundación Jiménez Díaz. Av. Reyes Católicos, 2. 28040-Madrid, Spain. jestebanmoreno@gmial.com; jesteban@fjd.es.
Rev Esp Quimioter ; 37(3): 266-269, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38602224
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Microbial Sensitivity Tests / Clarithromycin / Biofilms / Anti-Bacterial Agents / Nontuberculous Mycobacteria Limits: Humans Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Country of publication: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Microbial Sensitivity Tests / Clarithromycin / Biofilms / Anti-Bacterial Agents / Nontuberculous Mycobacteria Limits: Humans Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Country of publication: España